Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Daphne L. Wang"'
Autor:
Daphne L. Wang, Kelly B. Smith, Alona Muzikansky, Vanessa L. Merker, Scott R. Plotkin, Elyse R. Park, Ana-Maria Vranceanu
Publikováno v:
Journal of Neuro-Oncology. 122:127-133
Neurofibromatosis 1 (NF1) is a genetic disorder in which patients are at significantly increased risk for developing malignant peripheral nerve sheath tumors (MPNST) and malignant gliomas (brain cancer). We sought to develop a measure for assessing p
Publikováno v:
Psycho-Oncology. 22:2711-2719
Objective Neurofibromatosis (NF) 1 and 2 have distinct appearance effects, yet little research has examined patients' appearance concerns. We assessed appearance concerns and self-consciousness, self-esteem, and loneliness among women with NF. Method
Autor:
Scott R. Plotkin, Fawn Leigh, Kelly B. Smith, Alona Muzikansky, Sonia Esparza, Elyse R. Park, Daphne L. Wang
Publikováno v:
Genetics in Medicine. 14:977-982
Although patients with neurofibromatosis are predisposed to multiple nerve sheath tumors that can develop anywhere in the body and cause significant morbidity (e.g., hearing loss; pain), little research has examined emotional correlates of neurofibro
Autor:
Keith L. Ligon, William T. Curry, Tracy T. Batchelor, A. John Iafrate, Dora Dias-Santagata, Leif W. Ellisen, Darrell R. Borger, Charles D. Stiles, David N. Louis, Andrew S. Chi, Daphne L. Wang, Patrick Y. Wen
Publikováno v:
Journal of Neuro-Oncology. 110:89-98
Gliomas consist of multiple histologic and molecular subtypes with different clinical phenotypes and responsiveness to treatment. However, enrollment criteria for clinical trials still largely do not take into account these underlying molecular diffe
Autor:
Eunice L. Kwak, Andrew S. Chi, Tracy T. Batchelor, Daphne L. Wang, Keith D. Wilner, David N. Louis, A. John Iafrate, Jeffrey W. Clark
Publikováno v:
Journal of Clinical Oncology. 30:e30-e33
Publikováno v:
Current Cancer Therapy Reviews. 7:65-77
Publikováno v:
Neurology, vol 81, iss 1
Secondary malignancies due to alkylating agents or topoisomerase II inhibitors are a concern in patients treated for primary brain tumors of the nervous system. Myelosuppression is the dose-limiting toxic effect of the alkylating agent temozolomide;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75f2fa67494d9eb6f6145fed131e999c
https://escholarship.org/uc/item/3768d5zh
https://escholarship.org/uc/item/3768d5zh
Publikováno v:
Psycho-oncology. 22(12)
Neurofibromatosis (NF) 1 and 2 have distinct appearance effects, yet little research has examined patients' appearance concerns. We assessed appearance concerns and self-consciousness, self-esteem, and loneliness among women with NF.Women with NF1 (n
Publikováno v:
Lymphoma and Leukemia of the Nervous System ISBN: 9781441976673
The clinical presentation and radiographic appearance of PCNSL differ in immunocompetent and immunocompromised patients and are non-specific for both. A cranial MRI revealing a homogenously enhancing, single lesion in a periventricular location is su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9b5d8e8500d2dfcdae3fbb24dbe7aa2
https://doi.org/10.1007/978-1-4419-7668-0_6
https://doi.org/10.1007/978-1-4419-7668-0_6
Autor:
Victoria A. Joshi, Daphne L. Wang, Henning Willers, Kristopher T. Kahle, Thomas J. Lynch, Lecia V. Sequist, April F. Eichler, Jeffrey A. Engelman
A small subset of patients with nonsmall cell lung cancer (NSCLC) harbors mutations in the epidermal growth factor receptor (EGFR) that predict unique sensitivity to EGFR tyrosine kinase inhibitors (TKIs). The characteristics and behavior of brain me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b94d0d7aa1d98bad71911073cb51c5e
https://europepmc.org/articles/PMC3098020/
https://europepmc.org/articles/PMC3098020/